Diversity creates a strategic advantage. According to the BIO diversity report, people of color make up 32% of the biotech workforce. Yet, only 15% of executive teams and 14% of biotech company boards are inclusive of BIPOC (Black, Indigenous, People of Color). Representation matters! On this panel, you will hear from top VC’s and Entrepreneurs of color. They will share their experiences working in life sciences, discuss the challenges they faced, and how the industry will benefit from being more inclusive
– Ibraheem Badejo, PhD: Senior Director – New Ventures (Med Devices), Johnson & Johnson Innovation Center, Boston.
– Nick Davis, ScD: Founding Partner & CEO, Epitoire
– Roslyn Rawlins: Co-Founder and CEO, Bleuberi
– Uciane Scarlett, PhD: Principal at Oxford Sciences Innovation